Better pre-transplant treatment options for TP53-mutated MDS: cytoreductive or non-cytoreductive therapy?
Jiang B, Yang T, Zhao Y, Luo Y, Ouyang G, Yu J, Ye Y, Lan J, Lu Y, Lai X, Ye B, Chen Y, Liu L, Xu Y, Shi P, Xiao H, Hu H, Guo Q, Fu H, Wang X, Sun J, Zheng W, He J, Zhao Y, Wu W, Cai Z, Wei G, Huang H, Shi J.
Jiang B, et al. Among authors: wu w.
Bone Marrow Transplant. 2024 Dec 4. doi: 10.1038/s41409-024-02486-x. Online ahead of print.
Bone Marrow Transplant. 2024.
PMID: 39627346